Beta
72061

1H-NUCLEAR MAGNETIC RESONANCE (NMR) STUDY OF PIROXICAM-CYCLODEXTRINS INCLUSION COMPLEXES

Article

Last updated: 25 Dec 2024

Subjects

-

Tags

-

Abstract

A structural study of the inclusion compounds of piroxicam with cyclodextrins (a-, b- and g-) in different molar ratios was studied by means of 1H-nuclear magnetic resonance (NMR) spectroscopy. The change in the chemical shift suggested that the drug pyridine moity was included in the cavity of cyclodextrins and most of the protons shifted to lower field with increasing the concentration of cyclodextrins. Plots of the molar ratio of cyclodextrins vs. the change in the chemical shift f piroxicam indicated that a 1:1 complex was formed.

DOI

10.21608/bfsa.1989.72061

Authors

First Name

N.

Last Name

Omar

MiddleName

M.

Affiliation

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Assiut University, Assiut, Egypt

Email

-

City

-

Orcid

-

First Name

A.

Last Name

Ahmed

MiddleName

N.

Affiliation

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Assiut University, Assiut, Egypt

Email

-

City

-

Orcid

-

First Name

H.

Last Name

Ueda

MiddleName

-

Affiliation

Hoshi Institute of Pharmaceutical Sciences, Tokyo, Japan

Email

-

City

-

Orcid

-

First Name

S.

Last Name

El-Gizawy

MiddleName

M.

Affiliation

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Assiut University, Assiut, Egypt

Email

-

City

-

Orcid

-

Volume

12

Article Issue

2

Related Issue

10952

Issue Date

1989-12-01

Receive Date

1989-09-12

Publish Date

1989-12-31

Page Start

298

Page End

307

Print ISSN

1110-0052

Online ISSN

3009-7703

Link

https://bpsa.journals.ekb.eg/article_72061.html

Detail API

https://bpsa.journals.ekb.eg/service?article_code=72061

Order

8

Type

Original Article

Type Code

1,096

Publication Type

Journal

Publication Title

Bulletin of Pharmaceutical Sciences Assiut University

Publication Link

https://bpsa.journals.ekb.eg/

MainTitle

1H-NUCLEAR MAGNETIC RESONANCE (NMR) STUDY OF PIROXICAM-CYCLODEXTRINS INCLUSION COMPLEXES

Details

Type

Article

Created At

22 Jan 2023